Travelers Compan SEC Filings

Travelers (TRV) filed a Form 144 notice for a proposed sale of 25,000 shares of common stock. The filing lists an aggregate market value of $6,956,254.49, with Fidelity Brokerage Services as broker and the NYSE as the exchange. The approximate date of sale is 11/06/2025. The shares relate to an option granted on 02/02/2021, with cash payment on 11/06/2025.

This is a notice by a person for whose account the securities are to be sold under Rule 144 and does not represent an issuance by the company.

The Travelers Companies (TRV) Form 4: an executive officer (EVP & President, Personal Insurance) exercised 8,572 stock options at $132.58 on 10/28/2025 and sold 6,742 shares at a weighted average price of $270.5946 and 1,830 shares at a weighted average price of $271.2455 the same day. Following these transactions, direct holdings were 33,638.031 shares, with an additional 1,874.659 shares held indirectly in a 401(k) plan. The option grant covered 8,572 underlying shares and 30,000 derivative securities remained beneficially owned after the transactions.

TRV: A shareholder filed a Form 144 notice to sell up to 8,572 shares of common stock with an aggregate market value $2,320,728.19. The proposed sale is listed for 10/28/2025 through Fidelity Brokerage Services LLC on the NYSE. Shares outstanding were 223,063,417.

The notice indicates the shares derive from an option granted on 02/04/2020 and acquired on 10/28/2025 with cash payment. It also reports a prior sale by Michael Klein of 10,000 shares on 08/04/2025 for $2,619,855.

The Travelers Companies (TRV) reported stronger Q3 results. Total revenues were $12,470 million, up from $11,904 million a year ago, driven by higher premiums of $11,135 million and net investment income of $1,033 million. Net income rose to $1,888 million from $1,260 million, and diluted EPS increased to $8.24 from $5.42.

Profitability benefited from lower catastrophe losses of $402 million versus $939 million in the prior year period and higher segment income of $1,964 million versus $1,304 million. By segment this quarter, premiums were $5,700 million in Business Insurance, $1,042 million in Bond & Specialty, and $4,393 million in Personal Insurance.

Year to date, operating cash flow was $7,921 million. The company repurchased $625 million of shares in the quarter and paid $250 million in common dividends. Shareholders’ equity increased to $31,609 million as accumulated other comprehensive loss narrowed. TRV also agreed to sell its Canadian personal and most commercial insurance business for approximately $2.4 billion, retaining surety in Canada; the sale is subject to approvals and expected to close in the first quarter of 2026.

The Travelers Companies, Inc. (TRV) announced quarterly results for the period ended September 30, 2025, and made its third‑quarter financial supplement available on its website. The company furnished a press release and the supplement as Exhibits 99.1 and 99.2.

The materials are provided as furnished, not filed, under Form 8‑K General Instruction B.2.

The filing reports that Elizabeth Robinson, a director of The Travelers Companies, Inc. (TRV), received 11,264.077 deferred common stock units on 09/30/2025 as non‑cash compensation under the company’s Deferred Compensation Plan for Non‑Employee Directors. These units convert one‑for‑one into shares of common stock upon distribution, which the director may elect to receive as a lump sum or in annual installments. The reported amount includes 43.583 additional deferred units acquired on 09/30/2025 via the plan’s dividend reinvestment feature. The Form 4 was signed by power of attorney on 10/01/2025.

Russell G. Golden, a director of The Travelers Companies, Inc. (TRV), reported receipt of deferred common stock units as director compensation. On 09/30/2025 he was granted 165.64 deferred common stock units under the companys director deferred compensation plan, credited in lieu of cash compensation at an indicated per-share value of $279.22. After the grants and related holdings, he beneficially owned 4,355.693 common stock units, which include 16.442 units received on 09/30/2025 from dividend reinvestment. These deferred units convert one-for-one into shares on distribution and may be paid either in a lump sum or in annual installments under the plan. The Form 4 was signed by power of attorney on 10/01/2025.

Reporting person: Mojgan M. Lefebvre, EVP & Chief Technology & Operations Officer at The Travelers Companies, Inc. (TRV). The Form 4 discloses transactions on 08/22/2025 in which Ms. Lefebvre exercised 16,820 stock options with an exercise price of $132.58 and thereby acquired 16,820 shares of common stock. The same day she sold those 16,820 shares at a weighted average price of $277.5446, reducing her reported direct common stock holdings to 0 shares. The filing shows 9,213 derivative securities (stock options) remain beneficially owned following the reported activity. The filer certified the Form 4 on 08/26/2025 via power of attorney.

The Travelers Companies, Inc. (TRV) Form 4 shows insider transactions by Vice Chairman William H. Heyman on 08/22/2025. Mr. Heyman exercised stock options to acquire 2,000 shares at an exercise price of $139.83 per share and immediately recorded two sales of 1,000 shares each at $278 and $279. After these transactions his reported direct beneficial ownership in common stock stands at 255,085.534 shares, with additional indirect holdings of 1,704.115 shares through a 401(k) plan, 2,256 shares held by his spouse, and 250 shares held in trust for a stepson. The filing includes the option details (exercise date 08/22/2025; exercisable since 02/02/2024; expiration 02/02/2031) and a signature by power of attorney dated 08/26/2025.